Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,105 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Multi-institutional study of treatment patterns in Korean patients with WHO grade II gliomas: KNOG 15-02 and KROG 16-04 intergroup study.
Koo T, Lim DH, Seol HJ, Park CK, Kim IH, Chang JH, Lee J, Jung S, Gwak HS, Cho KH, Hong CK, Lee IJ, Kim E, Kim JH, Hong YK, Jang HS, Kim CY, Kim IA, Kim SH, Kim YI, Kim EY, Kim WC, Hong S. Koo T, et al. Among authors: kim ih, kim e, kim yi, kim ey, kim sh, kim cy, kim ia, kim wc, kim jh. J Neurooncol. 2018 Jul;138(3):667-677. doi: 10.1007/s11060-018-2839-z. Epub 2018 Mar 23. J Neurooncol. 2018. PMID: 29572674
Temozolomide salvage chemotherapy for recurrent anaplastic oligodendroglioma and oligo-astrocytoma.
Gwak HS, Yee GT, Park CK, Kim JW, Hong YK, Kang SG, Kim JH, Seol HJ, Jung TY, Chang JH, Yoo H, Hwang JH, Kim SH, Park BJ, Hwang SC, Kim MS, Kim SH, Kim EY, Kim E, Kim HY, Ko YC, Yun HJ, Youn JH, Kim J, Lee B, Lee SH. Gwak HS, et al. Among authors: kim e, kim hy, kim ey, kim sh, kim ms, kim j, kim jw, kim jh. J Korean Neurosurg Soc. 2013 Dec;54(6):489-95. doi: 10.3340/jkns.2013.54.6.489. Epub 2013 Dec 31. J Korean Neurosurg Soc. 2013. PMID: 24527191 Free PMC article.
Concurrent Chemoradiotherapy with Temozolomide Followed by Adjuvant Temozolomide for Newly Diagnosed Glioblastoma Patients: A Retrospective Multicenter Observation Study in Korea.
Kim BS, Seol HJ, Nam DH, Park CK, Kim IH, Kim TM, Kim JH, Cho YH, Yoon SM, Chang JH, Kang SG, Kim EH, Suh CO, Jung TY, Lee KH, Kim CY, Kim IA, Hong CK, Yoo H, Kim JH, Kang SH, Kang MK, Kim EY, Kim SH, Chung DS, Hwang SC, Song JH, Cho SJ, Lee SI, Lee YS, Ahn KJ, Kim SH, Lim DH, Gwak HS, Lee SH, Hong YK. Kim BS, et al. Among authors: kim ih, kim eh, kim ey, kim sh, kim cy, kim ia, kim tm, kim jh. Cancer Res Treat. 2017 Jan;49(1):193-203. doi: 10.4143/crt.2015.473. Epub 2016 Jun 27. Cancer Res Treat. 2017. PMID: 27384161 Free PMC article.
Impact of adjuvant treatments on survival in Korean patients with WHO grade II gliomas: KNOG 15-02 and KROG 16-04 intergroup study.
Koo T, Lim DH, Seol HJ, Dho YS, Kim IH, Chang JH, Lee J, Jung TY, Gwak HS, Cho KH, Hong CK, Lee IJ, Kim E, Kim JH, Hong YK, Jang HS, Kim CY, Kim IA, Kim SH, Kim YI, Kim EY, Kim WC, Hong S. Koo T, et al. Among authors: kim ih, kim e, kim yi, kim ey, kim sh, kim cy, kim ia, kim wc, kim jh. J Neurooncol. 2018 Nov;140(2):445-455. doi: 10.1007/s11060-018-2972-8. Epub 2018 Aug 10. J Neurooncol. 2018. PMID: 30097825
Concurrent and Adjuvant Temozolomide for Newly Diagnosed Grade III Gliomas without 1p/19q Co-deletion: A Randomized, Open-Label, Phase 2 Study (KNOG-1101 Study).
Hwang K, Kim TM, Park CK, Chang JH, Jung TY, Kim JH, Nam DH, Kim SH, Yoo H, Hong YK, Kim EY, Lee DE, Joo J, Kim YJ, Choe G, Choi BS, Kang SG, Kim JH, Kim CY. Hwang K, et al. Among authors: kim yj, kim ey, kim sh, kim cy, kim tm, kim jh. Cancer Res Treat. 2020 Apr;52(2):505-515. doi: 10.4143/crt.2019.421. Epub 2019 Oct 28. Cancer Res Treat. 2020. PMID: 31671938 Free PMC article. Clinical Trial.
Influence of Concurrent and Adjuvant Temozolomide on Health-Related Quality of Life of Patients with Grade III Gliomas: A Secondary Analysis of a Randomized Clinical Trial (KNOG-1101 Study).
Ahn GS, Hwang K, Kim TM, Park CK, Chang JH, Jung TY, Kim JH, Nam DH, Kim SH, Yoo H, Hong YK, Kim EY, Lee DE, Joo J, Kim YJ, Choe G, Choi BS, Kang SG, Kim JH, Kim CY. Ahn GS, et al. Among authors: kim yj, kim ey, kim sh, kim cy, kim tm, kim jh. Cancer Res Treat. 2022 Apr;54(2):396-405. doi: 10.4143/crt.2021.393. Epub 2021 Jul 6. Cancer Res Treat. 2022. PMID: 34237210 Free PMC article. Clinical Trial.
2,105 results